Fred Schwarzer, CEO and President at IGM Biosciences, Inc. (IGMS), sold 24,738 shares at $18.77 ($470K) on 2022-12-16, disclosed to the SEC on 2022-12-20.
Open-market sale of $470k IGMS by CEO and President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.77 | 7,955 | $149K | 31.8% |
| 2 | $18.77 | 7,955 | $149K | 31.8% |
| 3 | $19.36 | 4,414 | $85K | 18.2% |
| 4 | $19.36 | 4,414 | $85K | 18.2% |
| Total | $18.98 avg | 24,738 | $470K | 100% |
| Filing → |
| IGMS | SELL | 2024-03-15 | $90K | — | Filing → |
| IGMS | SELL | 2023-12-15 | $203K | — | Filing → |
| IGMS | SELL | 2023-11-29 | $7K | — | Filing → |